1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. VAXART INC
Vaxart Inc XNAS: VXRT
Weak Stock

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Vaxart Inc

The latest disclosure was made by Kevin P. Finney in Vaxart Inc where a trade of 794 Common Stock done at an average price of $0.4 was reported to US exchanges on July 17, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kevin P. Finney Director Purchase of securities on an exchange or from another person at price $ 0.38 per share. 17 Jul 2025 794 38,897 (0%) 0% 0.4 302 Common Stock
Kevin P. Finney Director Purchase of securities on an exchange or from another person at price $ 0.37 per share. 17 Jul 2025 50,000 204,771 (0%) 0% 0.4 18,500 Common Stock
Kevin P. Finney Director Purchase of securities on an exchange or from another person at price $ 0.35 per share. 17 Jul 2025 50,000 154,771 (0%) 0% 0.4 17,500 Common Stock
Kevin P. Finney Director Purchase of securities on an exchange or from another person at price $ 0.38 per share. 17 Jul 2025 25,874 104,771 (0%) 0% 0.4 9,832 Common Stock
Kevin P. Finney Director Purchase of securities on an exchange or from another person at price $ 0.40 per share. 17 Jul 2025 20,000 78,897 (0%) 0% 0.4 8,000 Common Stock
Kevin P. Finney Director Purchase of securities on an exchange or from another person at price $ 0.39 per share. 17 Jul 2025 20,000 58,897 (0%) 0% 0.4 7,800 Common Stock
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 95,400 95,400 - - Stock Option (right to buy)
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 16,000 56,566 (0%) 0% 0 Common Stock
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 95,400 95,400 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 16,000 702,840 (1%) 0% 0 Common Stock
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 95,400 95,400 - - Stock Option (right to buy)
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 16,000 46,750 (0%) 0% 0 Common Stock
Kevin P. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 36,392 36,392 - - Stock Option (right to buy)
Kevin P. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2025 6,103 38,103 (0%) 0% 0 Common Stock
Steven Lo Director, President, Chief Exec Officer Purchase of securities on an exchange or from another person at price $ 0.49 per share. 19 May 2025 100,000 100,000 (0%) 0% 0.5 49,000 Common Stock
Jeroen Grasman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2025 1,000,000 1,000,000 - - Stock Option (right to buy)
Jeroen Grasman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2025 350,000 350,000 (0%) 0% 0 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.42 per share. 28 Mar 2025 3,913 740,490 (1%) 0% 0.4 1,648 Common Stock
James F. Cummings Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.42 per share. 28 Mar 2025 3,292 745,757 (1%) 0% 0.4 1,387 Common Stock
Steven Lo Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 1,405,000 1,632,638 (3%) 2% 0 Common Stock
Steven Lo Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 2,108,000 2,108,000 - - Stock Option (right to buy)
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 610,000 610,000 - - Stock Option (right to buy)
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 406,000 744,403 (1%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 406,000 749,049 (1%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 610,000 610,000 - - Stock Option (right to buy)
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 50,000 50,000 - - Stock Option (right to buy)
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 406,000 694,123 (1%) 0% 0 Common Stock
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 50,000 50,000 - - Stock Option (right to buy)
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 610,000 610,000 - - Stock Option (right to buy)
Phillip E. Lee Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 610,000 610,000 - - Stock Option (right to buy)
Phillip E. Lee Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2025 406,000 631,619 (1%) 0% 0 Common Stock
Steven Lo Director, President, Chief Exec Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. 18 Mar 2025 22,362 227,638 (0%) 0% 0.6 12,751 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. 18 Mar 2025 8,050 338,403 (0%) 0% 0.6 4,590 Common Stock
Edward B. Berg SVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. 18 Mar 2025 8,050 288,123 (0%) 0% 0.6 4,590 Common Stock
Phillip E. Lee Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. 18 Mar 2025 8,050 225,619 (0%) 0% 0.6 4,590 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. 02 Feb 2025 9,242 346,453 (0%) 0% 0.7 6,283 Common Stock
James F. Cummings Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. 02 Feb 2025 7,964 318,837 (0%) 0% 0.7 5,414 Common Stock
Edward B. Berg SVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. 02 Feb 2025 9,242 261,464 (0%) 0% 0.7 6,283 Common Stock
Kevin Finney P. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 32,000 32,000 (0%) 0% 0 Common Stock
Kevin Finney P. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2025 190,800 190,800 - - Stock Option (right to buy)
Phillip E. Lee Chief Financial Officer 15 Dec 2024 6,132 233,669 (0%) 0% 0.6 3,630 Common Stock
Phillip E. Lee Chief Financial Officer 12 Jun 2024 2,007 239,801 (0%) 0% 0.8 1,525 Common Stock
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 95,400 95,400 - - Stock Option (right to buy)
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 16,000 40,566 (0%) 0% 0 Common Stock
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 95,400 95,400 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 16,000 686,840 (1%) 0% 0 Common Stock
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 16,000 30,750 (0%) 0% 0 Common Stock
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 95,400 95,400 - - Stock Option (right to buy)
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 95,400 95,400 - - Stock Option (right to buy)
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 16,000 34,490 (0%) 0% 0 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. 28 Mar 2024 3,902 355,695 (0%) 0% 1.3 5,073 Common Stock
James F. Cummings Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.30 per share. 28 Mar 2024 3,292 326,801 (0%) 0% 1.3 4,280 Common Stock
Steven Lo Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2024 250,000 250,000 (0%) 0% 0 Common Stock
Steven Lo Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Mar 2024 1,000,000 1,000,000 - - Stock Option (right to buy)
James F. Cummings Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. 08 Dec 2023 31,409 248,058 (0%) 0% 0.7 22,300 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2023 410,000 410,000 - - Stock Option (right to buy)
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2023 90,000 330,093 (0%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 08 Dec 2023 7,965 240,093 (0%) 0% 1.2 9,558 Common Stock
Edward B. Berg SVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. 08 Dec 2023 33,752 189,926 (0%) 0% 0.7 23,964 Common Stock
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2023 410,000 410,000 - - Stock Option (right to buy)
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2023 90,000 270,706 (0%) 0% 0 Common Stock
Edward B. Berg SVP, General Counsel Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 08 Dec 2023 9,220 180,706 (0%) 0% 1.2 11,064 Common Stock
Phillip E. Lee Chief Financial Officer 08 Dec 2023 5,943 151,808 (0%) 0% 0.6 3,744 Common Stock
Phillip E. Lee Chief Financial Officer 08 Dec 2023 410,000 410,000 - - Stock Option (right to buy)
Phillip E. Lee Chief Financial Officer 08 Dec 2023 90,000 241,808 (0%) 0% 0 Common Stock
Phillip E. Lee Chief Financial Officer 08 Dec 2023 35,151 157,751 (0%) 0% 0.7 24,957 Common Stock
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 6,922 24,566 (0%) 0% 0 Common Stock
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 41,510 41,510 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 44,224 44,224 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 7,375 670,840 (1%) 0% 0 Common Stock
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 44,224 44,224 - - Stock Option (right to buy)
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 7,375 14,750 (0%) 0% 0 Common Stock
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 7,375 18,490 (0%) 0% 0 Common Stock
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2023 44,224 44,224 - - Stock Option (right to buy)
Phillip E. Lee Chief Financial Officer 12 Jun 2023 102,500 102,500 - - Stock Option (right to buy)
Phillip E. Lee Chief Financial Officer 12 Jun 2023 22,500 192,902 (0%) 0% 0 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 410,000 410,000 - - Stock Option (right to buy)
Sean N. Tucker SVP, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. 28 Mar 2023 3,683 373,630 (0%) 0% 0.7 2,762 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.71 per share. 28 Mar 2023 34,288 339,342 (0%) 0% 0.7 24,344 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. 28 Mar 2023 9,220 330,122 (0%) 0% 1.2 11,064 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2023 90,000 420,122 (0%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. 28 Mar 2023 3,267 349,821 (0%) 0% 0.8 2,451 Common Stock
James F. Cummings Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. 28 Mar 2023 6,772 343,049 (0%) 0% 0.6 3,861 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 45,000 172,631 (0%) 0% 0 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 54,157 226,788 (0%) 0% 0 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 90,000 316,788 (0%) 0% 0 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 205,000 205,000 - - Stock Option (right to buy)
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 410,000 410,000 - - Stock Option (right to buy)
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 100,000 185,000 (0%) 0% 0 Common Stock
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 92,735 277,735 (0%) 0% 0 Common Stock
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 175,000 452,735 (0%) 0% 0 Common Stock
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 400,000 400,000 - - Stock Option (right to buy)
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 750,000 750,000 - - Stock Option (right to buy)
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 59,350 148,100 (0%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 90,000 238,100 (0%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 45,000 88,750 (0%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 410,000 410,000 - - Stock Option (right to buy)
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 205,000 205,000 - - Stock Option (right to buy)
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 205,000 205,000 - - Stock Option (right to buy)
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 410,000 410,000 - - Stock Option (right to buy)
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 90,000 187,606 (0%) 0% 0 Common Stock
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 52,606 97,606 (0%) 0% 0 Common Stock
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2023 45,000 45,000 (0%) 0% 0 Common Stock
Phillip E. Lee Chief Financial Officer 17 Mar 2023 205,000 205,000 - - Stock Option (right to buy)
Phillip E. Lee Chief Financial Officer 17 Mar 2023 56,652 170,402 (0%) 0% 0 Common Stock
Phillip E. Lee Chief Financial Officer 17 Mar 2023 45,000 113,750 (0%) 0% 0 Common Stock
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2022 88,448 88,448 - - Stock Option (right to buy)
Elaine J. Heron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2022 14,750 17,644 (0%) 0% 0 Common Stock
Robert A. Yedid Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Aug 2022 4,000 11,115 (0%) 0% - Common Stock
Robert A. Yedid Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Aug 2022 18,240 19,115 (0%) 0% - Common Stock
Robert A. Yedid Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Aug 2022 4,000 15,115 (0%) 0% - Common Stock
Robert A. Yedid Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Aug 2022 8,000 57,700 - - Stock Option (right to buy)
Robert A. Yedid Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Aug 2022 18,240 18,240 - - Stock Option (right to buy)
Robert A. Yedid Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.31 per share. 19 Aug 2022 18,240 29,355 (0%) 0% 0.3 5,654 Common Stock
Robert A. Yedid Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. 19 Aug 2022 8,000 37,355 (0%) 0% 2.4 19,120 Common Stock
Todd C. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 44,224 44,224 - - Stock Option (right to buy)
Todd C. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 7,375 125,905 (0%) 0% 0 Common Stock
Julie M. Cherrington Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 37,280 37,280 - - Stock Option (right to buy)
Julie M. Cherrington Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 6,217 6,217 (0%) 0% 0 Common Stock
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 7,375 663,465 (1%) 0% 0 Common Stock
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 44,224 44,224 - - Stock Option (right to buy)
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 7,375 7,375 (0%) 0% 0 Common Stock
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 44,224 44,224 - - Stock Option (right to buy)
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 7,375 11,115 (0%) 0% 0 Common Stock
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Aug 2022 44,224 44,224 - - Stock Option (right to buy)
Fuad Ahmad Interim CFO Purchase of securities on an exchange or from another person at price $ 3.22 per share. 22 Jun 2022 5,000 5,000 (0%) 0% 3.2 16,100 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Apr 2022 40,000 84,061 - - Stock Option (right to buy)
Sean N. Tucker SVP, Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. 22 Apr 2022 40,000 127,631 (0%) 0% 0.8 30,800 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 43,750 87,631 (0%) 0% 0 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 262,500 262,500 - - Stock Option (right to buy)
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 550,000 550,000 - - Stock Option (right to buy)
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 85,000 85,000 (0%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 43,750 43,750 (0%) 0% 0 Common Stock
James F. Cummings Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2022 262,500 262,500 - - Stock Option (right to buy)
Edward B. Berg SVP, General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2022 285,000 285,000 - - Stock Option (right to buy)
Robert A. Yedid Director Sale of securities on an exchange or to another person at price $ 6.01 per share. 10 Jan 2022 1,500 0 (0%) 0% 6.0 9,015 Common Stock
Todd C. Davis Director Gift of securities by or to the insider at price $ 0.00 per share. 22 Dec 2021 1,470 118,530 (0%) 0% 0 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. 30 Nov 2021 2,936 3,602 (0%) 0% 0.8 2,261 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 30 Nov 2021 666 666 (0%) 0% 5.2 3,443 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2021 2,936 26,416 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Nov 2021 666 1,667 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Sale of securities on an exchange or to another person at price $ 8.00 per share. 30 Nov 2021 3,602 0 (0%) 0% 8 28,816 Common Stock
Robert A. Yedid Director Gift of securities by or to the insider at price $ 0.00 per share. 12 Oct 2021 1,500 1,500 (0%) 0% - Common Stock
Robert A. Yedid Director Gift of securities by or to the insider at price $ 0.00 per share. 12 Oct 2021 1,500 3,740 (0%) 0% - Common Stock
Robert A. Yedid Director Gift of securities by or to the insider at price $ 0.00 per share. 12 Oct 2021 1,500 5,240 (0%) 0% - Common Stock
Robert A. Yedid Director Gift of securities by or to the insider at price $ 0.00 per share. 12 Oct 2021 1,500 6,740 (0%) 0% - Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 10 Sep 2021 334 334 (0%) 0% 5.2 1,727 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2021 1,467 29,352 - - Stock Option (Right to Buy)
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Sep 2021 334 2,333 - - Stock Option (Right to Buy)
Margaret Echerd SVP, Principal Accntng Officer Sale of securities on an exchange or to another person at price $ 9.10 per share. 10 Sep 2021 1,801 0 (0%) 0% 9.1 16,389 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. 10 Sep 2021 1,467 1,801 (0%) 0% 0.8 1,130 Common Stock
Julie M. Cherrington Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Aug 2021 65,700 65,700 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. 10 Aug 2021 1,468 1,801 (0%) 0% 0.8 1,130 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2021 1,468 30,819 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Aug 2021 333 2,667 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Sale of securities on an exchange or to another person at price $ 10.00 per share. 10 Aug 2021 1,801 0 (0%) 0% 10 18,010 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 10 Aug 2021 333 333 (0%) 0% 5.2 1,722 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 10.20 per share. 10 Aug 2021 5,828 51,465 (0%) 0% 10.2 59,446 Common Stock
Sean N. Tucker SVP, Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 10.20 per share. 10 Aug 2021 4,172 43,881 (0%) 0% 10.2 42,554 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2021 333 3,000 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 19 Jul 2021 333 333 (0%) 0% 5.2 1,722 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. 19 Jul 2021 1,467 1,800 (0%) 0% 0.8 1,130 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Sale of securities on an exchange or to another person at price $ 8.00 per share. 19 Jul 2021 1,800 0 (0%) 0% 8 14,400 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jul 2021 1,467 32,287 - - Stock Option (right to buy)
Michael J. Finney Director 18 Jun 2021 181,818 0 - - Common Stock Purchase Warrant
Michael J. Finney Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. 18 Jun 2021 9,000 461,572 (0%) 0% 0.7 6,120 Common Stock
Michael J. Finney Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. 18 Jun 2021 12,700 474,272 (0%) 0% 0.7 8,636 Common Stock
Michael J. Finney Director 18 Jun 2021 181,818 656,090 (1%) 0% 1.1 200,000 Common Stock
Michael J. Finney Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2021 9,000 0 - - Stock Option (right to buy)
Michael J. Finney Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2021 12,700 0 - - Stock Option (right to buy)
Todd C. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 15,097 15,097 - - Stock Option (right to buy)
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 15,097 15,097 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 100,000 100,000 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 15,097 15,097 - - Stock Option (right to buy)
Sean N. Tucker SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 100,000 100,000 - - Stock Option (right to buy)
David E. Wheadon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 65,700 65,700 - - Stock Option (right to buy)
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 15,097 15,097 - - Stock Option (right to buy)
Andrei Floroiu Director, President, Chief Exec Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 250,000 250,000 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. 09 Jun 2021 35,222 47,555 (0%) 0% 0.8 27,121 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2021 35,222 35,222 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Jun 2021 12,333 3,667 - - Stock Option (right to buy)
Margaret Echerd SVP, Principal Accntng Officer Sale of securities on an exchange or to another person at price $ 8.00 per share. 09 Jun 2021 47,555 0 (0%) 0% 8 380,440 Common Stock
Margaret Echerd SVP, Principal Accntng Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.17 per share. 09 Jun 2021 12,333 12,333 (0%) 0% 5.2 63,762 Common Stock
Wouter W. Latour Director Sale of securities on an exchange or to another person at price $ 6.54 per share. 06 May 2021 100,000 0 (0%) 0% 6.5 653,890 Common Stock
Wouter W. Latour Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2021 100,000 700,000 - - Stock Option (right to buy)
Wouter W. Latour Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 May 2021 100,000 800,000 - - Stock Option (right to buy)
Wouter W. Latour Director Sale of securities on an exchange or to another person at price $ 7.13 per share. 06 May 2021 100,000 0 (0%) 0% 7.1 712,750 Common Stock
Wouter W. Latour Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 06 May 2021 100,000 100,000 (0%) 0% 1.7 170,000 Common Stock
Wouter W. Latour Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share. 06 May 2021 100,000 100,000 (0%) 0% 1.7 170,000 Common Stock
Sean N. Tucker Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Mar 2021 1,006 0 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.49 per share. 16 Mar 2021 1,006 48,053 (0%) 0% 6.5 6,529 Common Stock
Wouter W. Latour Director Sale of securities on an exchange or to another person at price $ 6.04 per share. 04 Mar 2021 150,000 0 (0%) 0% 6.0 906,450 Common Stock
Wouter W. Latour Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Mar 2021 150,000 213,261 - - Stock Option (right to buy)
Wouter W. Latour Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.77 per share. 04 Mar 2021 150,000 150,000 (0%) 0% 0.8 115,500 Common Stock
Wouter W. Latour Director Sale of securities on an exchange or to another person at price $ 6.32 per share. 23 Nov 2020 333,334 0 (0%) 0% 6.3 2,108,138 Common Stock
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2020 65,700 65,700 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Aug 2020 4,026 0 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.49 per share. 13 Aug 2020 4,026 51,679 (0%) 0% 6.5 26,129 Common stock
Wouter W. Latour Director 12 Aug 2020 166,667 333,334 (0%) 0% 0.3 50,000 Common stock
Wouter W. Latour Director 12 Aug 2020 166,667 0 - - Common Stock Purchase Warrant
Andrei Floroiu Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2020 900,000 900,000 - - Stock Option (right to buy)
Andrei Floroiu Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2020 845,280 845,280 - - Stock Option (right to buy)
Todd C. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 65,700 65,700 - - Stock Option (right to buy)
Margaret Echerd VP, Corporate Controller, PAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 315,000 315,000 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 65,700 65,700 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 360,000 360,000 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 900,000 900,000 - - Stock Option (right to buy)
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 65,700 65,700 - - Stock Option (right to buy)
Andrei Floroiu Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2020 54,720 54,720 - - Stock Option (right to buy)
Todd C. Davis Director Sale of securities on an exchange or to another person at price $ 3.28 per share. 28 Apr 2020 60,000 120,000 (0%) 0% 3.3 196,500 Common stock
Todd C. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2019 54,720 54,720 - - Stock Option (right to buy)
Robert A. Yedid Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2019 54,720 54,720 - - Stock Option (right to buy)
John P. Richard Director Purchase of securities on an exchange or from another person at price $ 0.38 per share. 11 Oct 2019 20,000 20,000 (0%) 0% 0.4 7,680 Common stock
Wouter W. Latour Director, President and Chief Executive Purchase of securities on an exchange or from another person at price $ 0.30 per share. 30 Sep 2019 166,667 166,667 (0%) 0% 0.3 50,000 Common stock
Wouter W. Latour Director, President and Chief Executive Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Sep 2019 166,667 166,667 - - Common Stock Purchase Warrant
Anne M. Vanlent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 12,700 12,700 - - Stock Option (right to buy)
Anne M. Vanlent Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 9,000 9,000 - - Stock Option (right to buy)
Geoffrey F. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 9,000 9,000 - - Stock Option (right to buy)
Geoffrey F. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 12,700 12,700 - - Stock Option (right to buy)
John P. Richard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 12,700 12,700 - - Stock Option (right to buy)
John P. Richard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 9,000 9,000 - - Stock Option (right to buy)
Richard J. Markham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 9,000 9,000 - - Stock Option (right to buy)
Richard J. Markham Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 12,700 12,700 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 12,700 12,700 - - Stock Option (right to buy)
Michael J. Finney Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Jun 2019 9,000 9,000 - - Stock Option (right to buy)
Margaret Echerd VP, Corporate Controller, PAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2019 70,444 70,444 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2019 124,061 124,061 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2019 363,261 363,261 - - Stock Option (right to buy)
Michael J. Finney Director Purchase of securities on an exchange or from another person at price $ 1.10 per share. 11 Apr 2019 181,818 452,572 (0%) 1% 1.1 200,000 Common Stock
Michael J. Finney Director Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Apr 2019 181,818 181,818 - - Common Stock Warrant
Sean N. Tucker Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Apr 2019 27,273 27,273 - - Common Stock Warrant (right to buy)
Sean N. Tucker Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 1.10 per share. 11 Apr 2019 27,273 52,661 (0%) 0% 1.1 30,000 Common stock
John Harland Chief Financial Officer Other type of transaction at price $ 0.00 per share. 11 Sep 2018 761 761 (0%) 0% 0 Common Stock
Michael J. Finney None Other type of transaction at price $ 0.00 per share. 11 Sep 2018 34,958 270,754 (3%) 0% 0 Common Stock
Michael J. Finney None Purchase of securities on an exchange or from another person at price $ 2.91 per share. 04 Jun 2018 65 232,043 (3%) 0% 2.9 189 Common Stock
Michael J. Finney None Purchase of securities on an exchange or from another person at price $ 2.91 per share. 04 Jun 2018 800 233,978 (3%) 0% 2.9 2,328 Common Stock
Michael J. Finney None Purchase of securities on an exchange or from another person at price $ 3.46 per share. 04 Jun 2018 2,000 231,978 (3%) 0% 3.5 6,920 Common Stock
Michael J. Finney None Purchase of securities on an exchange or from another person at price $ 4.27 per share. 04 Jun 2018 1,000 229,978 (3%) 0% 4.3 4,270 Common Stock
Michael J. Finney None Purchase of securities on an exchange or from another person at price $ 2.92 per share. 04 Jun 2018 1,135 233,178 (3%) 0% 2.9 3,314 Common Stock
John Harland Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2018 18,000 18,000 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2018 14,000 14,000 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2018 110,700 110,700 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Mar 2018 2,013 0 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.49 per share. 12 Mar 2018 2,013 47,653 (0%) 0% 6.5 13,064 Common Stock
Jan Leschly Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 30,793,670 30,793,670 (39%) 39% 0 Common Stock
Richard J. Markham Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 30,793,670 30,793,670 (39%) 39% 0 Common Stock
John Harland Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 4,087 4,087 - - Stock Option (right to buy)
John Harland Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 9,563 9,563 - - Stock Option (right to buy)
John Harland Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 8,255 8,255 - - Stock Option (right to buy)
John Harland Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 7,047 7,047 - - Stock Option (right to buy)
Michael J. Finney None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 1,818 230,796 (0%) 0% 0 Common Stock
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 2,014 2,014 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 4,027 4,027 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 9,060 9,060 - - Stock Optin (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 7,731 7,731 - - Stock Optin (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 10,067 10,067 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 11,604 11,604 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 10,523 10,523 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 3,020 3,020 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 1,006 1,006 - - Stock Option (right to buy)
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 45,640 45,640 (0%) 0% 0 Common Stock
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 9,060 9,060 (0%) 0% 0 Common Stock
Sean N. Tucker Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 25,388 25,388 (0%) 0% 0 Common Stock
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 18,120 18,120 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 14,908 14,908 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 13,256 13,256 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 9,442 9,442 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 6,536 6,536 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 10,731 10,731 - - Stock Option (right to buy)
Wouter W. Latour Director, President and Chief Executive Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2018 23,651 23,651 - - Stock Option (right to buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2017 20,000 105,000 - - Stock Option (Right to Buy)
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2017 20,000 103,332 - - Stock Option (Right to Buy)
Armando Anido None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2017 20,000 75,000 - - Stock Option (Right to Buy)
Anne M. Vanlent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2017 20,000 105,000 - - Stock Option (Right to Buy)
Russell H. Plumb None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2017 20,000 622,453 - - Stock Option (Right to Buy)
John P Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2017 20,000 105,000 - - Stock Option (Right to Buy)
Michael W. Dunne None Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2017 20,000 75,000 - - Stock Option (Right to Buy)
Mark P. Colonnese Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2017 400,000 775,000 - - Stock Option (Right to Buy)
Joseph M. Patti Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Apr 2017 650,000 2,113,304 - - Stock Option (Right to Buy)
Joseph M. Patti Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2016 380,000 1,478,929 - - Stock Option (Right to Buy)
Mark P. Colonnese CFO and EVP Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jul 2016 150,000 375,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
Armando Anido None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
Anne M. Vanlent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
Russell H. Plumb None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
John P Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
Michael W. Dunne None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2016 20,000 20,000 - - Stock Option (Right to Buy)
Russell H. Plumb Director, Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2016 9,167 9,167 - - Stock Option (Right to Buy)
Mark P. Colonnese Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Feb 2016 6,700 7,000 - - Common Stock
Mark P. Colonnese Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Feb 2016 300 300 - - Common Stock
Mark P. Colonnese Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2015 225,000 225,000 - - Stock Option (Right to Buy)
Joseph M. Patti Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Sep 2015 2,500 126,128 - - Common stock
Joseph M. Patti Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 25 Sep 2015 2,500 123,628 - - Common stock
Armando Anido None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Sep 2015 35,000 35,000 - - Stock Option (Right to Buy)
Michael W. Dunne None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Sep 2015 35,000 35,000 - - Stock Option (Right to Buy)
Russell H. Plumb Director, Executive Chairman Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 16 Sep 2015 12,140 203,213 - - Common Stock
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2015 5,000 5,000 - - Stock Option (Right to Buy)
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2015 5,000 5,000 - - Stock Option (Right to Buy)
Anne M. Vanlent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2015 5,000 5,000 - - Stock Option (Right to Buy)
Joseph M. Patti Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2015 250,000 250,000 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2015 5,000 5,000 - - Stock Option (Right to Buy)
James Fox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2015 2,500 2,500 - - Restricted Stock Unit
Peter Azzarello Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Aug 2015 85,000 85,000 - - Stock Option (Right to Buy)
Anne M. Vanlent None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 22 Jun 2015 35,000 35,000 - - Common Stock
James Fox None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2015 70,000 100,614 - - Common stock
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2015 15,000 15,000 - - Stock Option (Right to Buy)
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2015 15,000 15,000 - - Stock Option (Right to Buy)
Anne M. Vanlent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2015 15,000 15,000 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2015 15,000 15,000 - - Stock Option (Right to Buy)
James Fox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2015 7,500 7,500 - - Restricted Stock Unit
Joseph M. Patti Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Mar 2015 10,000 121,128 - - Common stock
Joseph M. Patti Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Mar 2015 10,000 111,128 - - Common stock
Russell H. Plumb Director, Vice Chairmen Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 40,000 40,000 - - Restricted Stock Unit
Joseph M. Patti CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 475,000 475,000 - - Stock Option (right to buy)
Peter Azzarello Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2014 130,000 130,000 - - Stock Option (right to buy)
Joseph M. Patti EVP, Corporate Dev & Strategy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 30 Jun 2014 10,000 68,241 - - Common Stock
Joseph M. Patti EVP, Corporate Dev & Strategy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2014 800 67,241 - - Common Stockli
Joseph M. Patti EVP, Corporate Dev & Strategy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2014 4,200 66,441 - - Common Stock
Russell H. Plumb Director, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 4,331 102,579 - - Common Stock
Russell H. Plumb Director, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 2,700 98,248 - - Common Stock
Russell H. Plumb Director, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 2,310 104,889 - - Common Stock
Russell H. Plumb Director, CEO & President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 22,690 127,579 - - Common Stock
Joseph M. Patti EVP, Corporate Dev & Strategy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 2,621 62,241 - - Common Stock
Joseph M. Patti EVP, Corporate Dev & Strategy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 2,995 59,620 - - Common Stock
Joseph M. Patti EVP, Corporate Dev & Strategy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 8,451 56,225 - - Common Stock
Joseph M. Patti EVP, Corporate Dev & Strategy Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 Jun 2014 400 56,625 - - Common Stock
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2014 15,000 15,000 - - Stock Option (Right to Buy)
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2014 15,000 15,000 - - Stock Option (Right to Buy)
Anne M. Vanlent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2014 15,000 15,000 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2014 15,000 15,000 - - Stock Option (Right to Buy)
James Fox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2014 7,500 7,500 - - Restricted Stock Unit
Richard Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2014 7,500 7,500 - - Restricted Stock Unit
Russell H. Plumb Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2013 25,000 25,000 - - Market Stock Units
Russell H. Plumb Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2013 100,000 100,000 - - Stock Option (Right to Buy)
Joseph M. Patti EVP, Corporate Dev & Strategy Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2013 62,500 62,500 - - Stock Option (Right to Buy)
Joseph M. Patti EVP, Corporate Dev & Strategy Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2013 15,625 15,625 - - Market Stock Units
Peter Azzarello Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2013 4,375 4,375 - - Market Stock Units
Peter Azzarello Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2013 17,500 17,500 - - Stock Option (Right to Buy)
John P. Richard None Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2013 30,000 30,000 - - Stock Option (Right to Buy)
Michael R. Dougherty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2013 30,000 30,000 - - Stock Option (Right to Buy)
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2013 15,000 15,000 - - Stock Option (Right to Buy)
Peter Cook None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2013 8,700 100,127 - - Common Stock
Anne M. Vanlent None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2013 30,000 30,000 - - Stock Option (Right to Buy)
James Fox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2013 8,700 8,700 - - Common Stock
Jeffery Errington None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2013 15,000 15,000 - - Stock Option (Right to Buy)
Richard Hill None Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 May 2013 8,700 9,950 - - Common Stock
Russell H. Plumb Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2012 573,286 573,286 - - Stock Option (Right to Buy)
Russell H. Plumb Director, CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2012 143,322 143,322 - - Common Stock
Joseph M. Patti EVP, Corporate Dev & Strategy Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2012 358,304 358,304 - - Stock Option (Right to Buy)
Joseph M. Patti EVP, Corporate Dev & Strategy Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2012 71,661 71,661 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2012 5,167 105,128 - - Common Stock
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2011 40,000 40,000 - - Stock Option (right to buy)
Timothy P. Lynch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2011 20,000 20,000 - - Stock Option (right to buy)
David L. Castaldi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2011 20,000 20,000 - - Stock Option (right to buy)
Richard A. Harvey None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2011 20,000 20,000 - - Stock Option (right to buy)
Peter B. Davis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2011 20,000 20,000 - - Stock Option (right to buy)
Jason M. Aryeh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2011 20,000 20,000 - - Stock Option (right to buy)
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 May 2011 7,500 115,171 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 May 2011 4,876 110,295 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Other type of transaction at price $ 0.00 per share. 01 Apr 2011 3,096 333,733 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Other type of transaction at price $ 0.00 per share. 01 Apr 2011 3,023 336,756 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2011 50,000 386,756 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2011 13,283 373,473 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2011 150,000 150,000 - - Stock Option (right to buy)
Paul Kessler SVP Clinical, Med. & Reg.; CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2011 90,000 90,000 - - Stock Option (right to buy)
Paul Kessler SVP Clinical, Med. & Reg.; CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2011 36,000 131,267 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2011 8,596 122,671 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2011 75,000 75,000 - - Stock Option (right to buy)
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2011 6,300 41,050 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2011 30,000 71,050 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Mar 2011 4,900 131,783 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Mar 2011 2,400 137,683 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 14 Mar 2011 1,000 136,683 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Mar 2011 9,900 144,983 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Mar 2011 4,900 140,083 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Mar 2011 9,900 154,883 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Jan 2011 3,181 330,637 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Jan 2011 2,985 95,267 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 27 Dec 2010 15,093 0 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Dec 2010 1,907 15,093 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Dec 2010 4,705 181,783 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Dec 2010 6,700 186,488 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2010 4,900 196,483 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2010 463 196,020 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Nov 2010 2,832 193,188 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Nov 2010 4,900 201,383 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Nov 2010 6,400 217,483 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Nov 2010 11,200 206,283 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Oct 2010 12,020 232,436 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Oct 2010 8,553 223,883 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Oct 2010 4,422 244,456 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Aug 2010 600 248,878 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Jul 2010 1,500 44,225 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Jul 2010 1,625 45,725 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Jun 2010 2,147 249,478 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 03 Jun 2010 258 251,625 - - Common Stock
Geoffrey F. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2010 40,000 40,000 - - Stock Option (right to buy)
Geoffrey F. Cox None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 May 2010 1,908 25,679 - - Common Stock
Timothy P. Lynch None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2010 20,000 20,000 - - Stock Option (right to buy)
David L. Castaldi None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2010 20,000 20,000 - - Stock Option (right to buy)
Richard A. Harvey None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2010 20,000 20,000 - - Stock Option (right to buy)
Peter B. Davis None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2010 20,000 20,000 - - Stock Option (right to buy)
Peter B. Davis None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 May 2010 3,816 14,630 - - Common Stock
Jason M. Aryeh None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2010 20,000 20,000 - - Stock Option (right to buy)
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 300 112,952 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 50 112,902 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 850 112,052 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 1,000 111,052 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 3,205 107,847 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 700 107,147 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 3,592 103,555 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 100 103,455 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 1,900 101,555 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 100 101,455 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 1,400 100,055 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 1,003 99,052 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 600 98,452 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 May 2010 200 98,252 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Apr 2010 2,250 47,350 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 200 114,952 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 500 114,452 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 600 113,852 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 600 113,252 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 200 118,300 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 928 117,372 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 1,520 115,852 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 05 Apr 2010 700 115,152 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2010 125,000 125,000 - - Stock Option (Right to Buy)
Raafat E.F. Fahim Director, President, CEO and CFO Other type of transaction at price $ 0.00 per share. 01 Apr 2010 5,404 278,414 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Other type of transaction at price $ 0.00 per share. 01 Apr 2010 5,404 283,818 - - Common Stock
Raafat E.F. Fahim Director, President, CEO and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2010 50,000 333,818 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2010 90,000 90,000 - - Stock Option (Right to Buy)
Paul Kessler SVP Clinical, Med. & Reg.; CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2010 36,000 118,500 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2010 24,000 53,650 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2010 250 53,400 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2010 400 53,000 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 01 Apr 2010 1,300 51,700 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops 01 Apr 2010 2,100 49,600 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2010 60,000 60,000 - - Stock Option (Right to Buy)
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Mar 2010 64,793 252,117 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Mar 2010 234 251,883 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Mar 2010 28,510 316,910 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Mar 2010 7,800 345,420 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Mar 2010 6,381 352,820 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 18 Mar 2010 200 352,620 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Mar 2010 8,800 361,820 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Mar 2010 2,619 359,201 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Mar 2010 9,873 29,650 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 15 Mar 2010 200 370,620 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Mar 2010 1,000 1,000 - - Stock Option (right to buy)
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Mar 2010 180,700 387,420 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Mar 2010 1,125 14,625 - - Stock Option (Right to Buy)
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Mar 2010 1,125 40,648 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 11 Mar 2010 1,125 39,523 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 10 Mar 2010 16,100 568,120 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 08 Mar 2010 3,200 584,220 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2010 2,250 15,750 - - Stock Option (Right to Buy)
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Other type of transaction at price $ 0.00 per share. 02 Mar 2010 5,404 39,523 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Mar 2010 2,250 41,773 - - Common Stock
Matthew W. Kalnik SVP Strategic Plan. & Bus. Ops Sale of securities on an exchange or to another person at price $ 0.00 per share. 02 Mar 2010 2,250 39,523 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 13 Jan 2010 13,800 587,420 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 12 Jan 2010 86,200 601,220 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Jan 2010 42,365 737,020 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Jan 2010 3,443 733,577 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 06 Jan 2010 46,157 687,420 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 22 Dec 2009 8,035 779,385 - - Common stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Dec 2009 4,045 787,420 - - Common Stock
Peter B. Davis None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Nov 2009 800 8,614 - - Common stock
Peter B. Davis None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Nov 2009 2,200 10,814 - - Common stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Nov 2009 602 82,500 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Nov 2009 2,000 95,740 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Nov 2009 7,136 88,604 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Nov 2009 5,502 83,102 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Nov 2009 2,500 98,740 - - Common Stock
Paul Kessler SVP Clinical, Med. & Reg.; CMO Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Nov 2009 1,000 97,740 - - Common Stock
Timothy P. Lynch None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 3,846 0 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 500 917,965 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 500 917,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 5,000 912,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 300 912,165 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 100 912,065 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 6,232 905,833 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 1,909 903,924 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 10,058 893,866 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 2,100 891,766 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 10,335 881,431 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 33,803 847,628 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 43,163 804,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 1,000 803,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 1,000 802,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 500 801,965 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 500 801,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 5,000 796,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 200 977,174 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 58,709 918,465 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 4,804 791,661 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 17 Nov 2009 196 791,465 - - Common Stock
Jason M. Aryeh None 16 Nov 2009 17,000 1,232,650 - - Common Stock
Jason M. Aryeh None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Nov 2009 2,884 1,229,766 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters